Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators..

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

Epilepsy and religious experiences: Voodoo possession.

Carrazana E, DeToledo J, Tatum W, Rivas-Vasquez R, Rey G, Wheeler S.

Epilepsia. 1999 Feb;40(2):239-41.

Supplemental Content

Loading ...
Support Center